Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity.

Zemel MB, Shi H.

Nutr Rev. 2000 Jun;58(6):177-80. Review.

PMID:
10885325
2.

Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.

Yaswen L, Diehl N, Brennan MB, Hochgeschwender U.

Nat Med. 1999 Sep;5(9):1066-70.

PMID:
10470087
4.

Knockout studies defining different roles for melanocortin receptors in energy homeostasis.

Butler AA, Cone RD.

Ann N Y Acad Sci. 2003 Jun;994:240-5.

PMID:
12851322
5.

Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.

Abbott CR, Rossi M, Kim M, AlAhmed SH, Taylor GM, Ghatei MA, Smith DM, Bloom SR.

Brain Res. 2000 Jun 30;869(1-2):203-10.

PMID:
10865075
6.

Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice.

Weide K, Christ N, Moar KM, Arens J, Hinney A, Mercer JG, Eiden S, Schmidt I.

Physiol Genomics. 2003 Mar 18;13(1):47-56.

7.

Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.

Tatro JB.

Neuroimmunomodulation. 1996 Sep-Oct;3(5):259-84. Review.

PMID:
9218248
8.

Leptin and melanocortin signaling in the hypothalamus.

Bjørbaek C, Hollenberg AN.

Vitam Horm. 2002;65:281-311. Review.

PMID:
12481551
9.

The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models.

Yeo GS, Farooqi IS, Challis BG, Jackson RS, O'Rahilly S.

QJM. 2000 Jan;93(1):7-14. Review.

10.

[Genetic abnormalities of regulatory mechanism of appetite].

Arai K, Shibasaki T.

Nihon Rinsho. 2001 Mar;59(3):449-55. Review. Japanese.

PMID:
11268592
11.

Melanocortin activation of nucleus of the solitary tract avoids anorectic tachyphylaxis and induces prolonged weight loss.

Li G, Zhang Y, Rodrigues E, Zheng D, Matheny M, Cheng KY, Scarpace PJ.

Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E252-8. Epub 2007 Mar 27.

12.

Expression of functional melanocortin receptors and proopiomelanocortin peptides by human dermal microvascular endothelial cells.

Scholzen TE, Brzoska T, Kalden DH, Hartmeyer M, Fastrich M, Luger TA, Armstrong CA, Ansel JC.

Ann N Y Acad Sci. 1999 Oct 20;885:239-53. Review.

PMID:
10816657
13.

Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands.

Pritchard LE, Armstrong D, Davies N, Oliver RL, Schmitz CA, Brennand JC, Wilkinson GF, White A.

J Endocrinol. 2004 Jan;180(1):183-91.

14.
15.

Melanocortins and cardiovascular regulation.

Versteeg DH, Van Bergen P, Adan RA, De Wildt DJ.

Eur J Pharmacol. 1998 Oct 30;360(1):1-14. Review.

PMID:
9845266
16.

The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box.

Williams G, Harrold JA, Cutler DJ.

Proc Nutr Soc. 2000 Aug;59(3):385-96. Review.

PMID:
10997654
17.

Obesity, diabetes and functions for proopiomelanocortin-derived peptides.

Mountjoy KG, Wong J.

Mol Cell Endocrinol. 1997 Apr 4;128(1-2):171-7. Review.

PMID:
9140088
18.

Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse.

Martin NM, Small CJ, Sajedi A, Liao XH, Weiss RE, Gardiner JV, Ghatei MA, Bloom SR.

Regul Pept. 2004 Nov 15;122(3):169-72.

PMID:
15491787
19.

The melanocortin receptors: lessons from knockout models.

Butler AA, Cone RD.

Neuropeptides. 2002 Apr-Jun;36(2-3):77-84. Review.

PMID:
12359499
20.

Different developmental patterns of melanocortin MC3 and MC4 receptor mRNA: predominance of Mc4 in fetal rat nervous system.

Kistler-Heer V, Lauber ME, Lichtensteiger W.

J Neuroendocrinol. 1998 Feb;10(2):133-46.

PMID:
9535059
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk